7.12
0.19 (2.74%)
0.19 (2.74%)
Upgrade to Real-Time
Afterhours
Low
2.10
High
24.90
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vaxart Inc | VXRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.19 | 2.74% | 7.12 | 19:15:03 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 6.7545 | 6.70 | 7.46 | 7.20 | 6.93 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 7.12 | 7.15 | 0.03 | - | 1 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 50,766 | 11,754,479 | $ 7.17 | $ 84,289,985 | 27,382,455 | 2.10 - 24.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:15:03 | formt | 103 | $ 7.12 | USD |
Vaxart Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 842.03M | 117.77M | 91.83M | $ 4.05M | $ - | -0.35 | -30.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | -150.00k | 2.30% |
Vaxart News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.54 | 11.108 | 6.33 | 8.95 | 66,728,854 | -2.42 | -25.37% |
| 1 Month | 5.70 | 11.108 | 4.862 | 8.57 | 38,735,149 | 1.42 | 24.91% |
| 3 Months | 8.52 | 11.108 | 4.862 | 8.16 | 16,968,102 | -1.40 | -16.43% |
| 6 Months | 4.825 | 24.90 | 3.50 | 8.72 | 17,003,812 | 2.30 | 47.56% |
| 1 Year | 2.52 | 24.90 | 2.10 | 8.71 | 18,786,895 | 4.60 | 182.54% |
| 3 Years | 5.47 | 24.90 | 0.2543 | 7.40 | 7,797,742 | 1.65 | 30.16% |
| 5 Years | 17.71 | 24.90 | 0.2543 | 7.41 | 4,848,740 | -10.59 | -59.8% |
Vaxart Description
| Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. |
